# ICOSAPENT ETHYL
> **ANDA209525** · Abbreviated New Drug Application (Generic) · Sponsor: TEVA PHARMS USA · Approved 2020-09-11
## Drug
- **FDA Application Number:** ANDA209525
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** ICOSAPENT ETHYL
- **Generic name:** ICOSAPENT ETHYL
- **Active ingredients:** ICOSAPENT ETHYL
- **Dosage form:** CAPSULE
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** TEVA PHARMS USA
- **Manufacturer:** Teva Pharmaceuticals, Inc.
- **First approval:** 2020-09-11
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209525)
---
*MORVS · CC0 1.0*